chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hard time getting out of the bed; hard time to sleep; hard time walking; hard time getting out of the bed; intense body aches; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (hard time getting out of the bed), INSOMNIA (hard time to sleep), GAIT DISTURBANCE (hard time walking), DISCOMFORT (hard time getting out of the bed) and MYALGIA (intense body aches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H216, 026A21A and 026M21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fibromatosis, Arthritis, Blood pressure high and Sacroiliitis.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (hard time getting out of the bed), INSOMNIA (hard time to sleep), GAIT DISTURBANCE (hard time walking), DISCOMFORT (hard time getting out of the bed), MYALGIA (intense body aches) and ARTHRALGIA (joint pain). At the time of the report, FATIGUE (hard time getting out of the bed), INSOMNIA (hard time to sleep), GAIT DISTURBANCE (hard time walking), DISCOMFORT (hard time getting out of the bed), MYALGIA (intense body aches) and ARTHRALGIA (joint pain) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Hepatic enzyme increased: elevated (High) Elevated.         Concomitant medication was not reported.  Patient did not have any reaction from the 1 and 2 shots.  Treatment information was not reported.   This case was linked to MOD-2021-406482 (Patient Link).
The patient developed a headache on 4/6/21 (vaccine #1 on 3/30) and one week after that was admitted to the hospital for fluent aphasia and diplopia from hemorrhagic stroke with sinus venous thromobsis noted on MRI the next day.  Hospital course was complicated by  partial complex seizures.  She was admitted to hospital 4/13-4/19.
Report A0384624A describes the occurrence of mercury poisoning in an 18 month old male who received hep B vaccine recombinant (Engerix B). This report was received as a result of litigation proceedings and has not been confirmed by a physician or other healthcare professional. The subject "was born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, the subject achieved every developmental milestone anticipated of all normally developing children until the age of 18 months. The subject received injections of Engerix B on 4/22/93 (lot 1092A2) and 10/12/93 (1268B2). The subject also received diphtheria and tetanus toxoids  and pertussis vaccine (6/15/93 and 8/27/93), combination diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed/Haemophilus influenzae type B conjugate vaccine (Tetramune 10/12/93), diphtheria and tetanus toxoids and accullular pertussis vaccine adsorbed (Acel0Imune 9/15/94), and Haemophilus influenzae type B conjugate vaccine (Hib-Titer 6/15/93 and 8/27/93). The attorney alleged that "At approximately 18 months of age, the subject was neurologically devastated by the accumulation of mercury in his body, having been exposed via intramuscular vaccinations, and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect." Info received on 10/22/02 did not specify the outcomes of these events. The events of mercury poisoning and developmental regression in this report are considered medically serious (OMIC).
bad side effects from both of my doses/awfully to both dose; This spontaneous case was reported by another health care professional and describes the occurrence of VACCINATION COMPLICATION (bad side effects from both of my doses/awfully to both dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (bad side effects from both of my doses/awfully to both dose). At the time of the report, VACCINATION COMPLICATION (bad side effects from both of my doses/awfully to both dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication use was reported.   This case was linked to MOD-2021-406474 (Patient Link).   Reporter did not allow further contact
Ulcerative colitis; fever; lost over 20 pounds; extreme fatigue; chills; severe body aches; severe headache; A spontaneous report, was received from a  consumer concerning himself a 38 male patient , who was administered Moderna's COVID-19 vaccine (mRNA-1273) and experienced an ulcerative colitis, chills, severe body aches, fever, severe headache, extreme fatigue, lost over 20 pounds .  The patient's medical history was not provided by the reporter. Concomitant medications included Seroquel 15mg, Clonazepam 0.25mg, Omeprazole, Albuterol.  On 05 FEB 2021 the patient received their second of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in left arm for prophylaxis of COVID-19 infection.  On 05 MAR 2021, the patient experienced headache, body ache, chills .on 11 MAR 2021,The patient experienced ulcerative colitis, lost 20 pounds, fever. the ulcerative colitis flared up after second dose . patient have the predisposition and overactive immune system". the patient was not hospitalized.   The treatment taken by the patient was IV 3 rounds of Gluthathione hydrocortisone suppositories, herbal supplements, ibuprofen  The Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The  outcome of the events were considered as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. The causality of the event ulcerative colitis (UC) is related to the patient's past medical history of UC.
tongue is a lot swollen; Dizziness; Nausea; feeling weak; tired and washed out; swollen glands; This is a spontaneous report from a contactable consumer.  A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at single dose for COVID-19 immunisation.  The patient medical history and the concomitant medications were not reported. The patient was experiencing dizziness and right after the vaccine had dizziness and nausea. She said that the nausea went away after eating something. She said that he also feels like his tongue was swollen. The patient said that he feels like his tongue is a lot swollen. He stated that he had the shot 4 hours and when he gets up off of the chair, he can barely stand up because he is so dizzy. He said that he is also feeling weak, tired, and washed out. He said that he also has swollen glands. The event tongue is a lot swollen was serious as Life threatening, and Emergency Room Visit and Physician Office Visit. The outcome was unknown.  Information on the Batch/Lot number has been requested.
~1 week after vaccination, noticing weakness of entire left arm (not hands or fingers). ~9-10 days after vaccination, painful streak volar left arm from wrist to axilla.
Within 3 days, the pt developed an injection site reaction characterized by soreness, redness, swelling and warmth. The pt recovered.
Breakthrough case after Covid vaccination. Dose # 1 4/9/2021. C/O fever, muscle aches, fatigue, cough , SOA, and nausea/vomiting/ onset 9/15/21
admitted to hospital with mild symptoms  - patient recieved two doses of vaccine > 2 weeks
Vaccine admin @ approx 1430 on 9/11/19 and at 1730 9/11/19 noticed Hives + intermittent fever (TMaX 101.7) Hives resolved (self resolved w/o tx) evening of 9/12/19 + Fevers resolved 9/17/19. Pt. now asymptomatic.
After first Moderna vaccine, was incapacitated (flu-like symptoms - body aches, pains, tiredness) for first day. Afterwards  (within 2 days) began experiencing numbness, tingling and pain in both feet, as well as chest pain and shortness of breath. Visited PCM on 7 May 21 - schedule MRI, ECHO, and pulmonology. Symptoms intensified and began moving up both legs, followed by numbness in both arms. Over a 2-3 week period. 17 May 21 - Appointment with PCM - follow up and discuss results of MRI. While waiting for appointment, symptoms became intolerable, could not sit, lay, sleep, etc. without constant pain. Prescribed Prednisone, Gabapentin.  Referred to Neurosurgeon due to MRI results (Disc bulges L4/L5). Additional information for Item 18:  27 May 21 - Neurosurgeon visit - symptoms exceed disc bulges revealed in MRI - Referred to Neurology. 10 Jun 21 - Neurology - intake and evaluation - referred for Nerve Conduction Test. 23 Jun 21 - Nerve Conduction Test (NCV) 12 July 21 - Neurology - Discussed results of NCV - Normal - prescribed Lyrica. Referred for MRI.   Related information: Son, 28 yr old, received 1st Moderna vaccine on 12 Jul 21 and woke with similar symptoms (leg pain/numbness) on 18 Jul 21 treatment ongoing.
I experienced and corrected 3cognitive impairments; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via unspecified route of administration on right arm on 03Mar2021 at 09:45 (at the age of 59-years-old) as single dose for COVID-19 immunisation. Medical history was reported as animal dander, pollen allergies and sulfa drugs. The concomitant medications included fexofenadine hydrochloride (ALLEGRA), mometasone furoate (FLONASE), fisetin (MANUFACTURER UNKNOWN), ascorbic acid, calcium, minerals nos, retinol, tocopheryl acetate, Vitamin b nos, Vitamins nos, zinc (CENTRUM SILVER) and vit d nos (MANUFACTURER UNKNOWN) for an unknown indication on unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW6199) via unspecified route of administration in left arm on unknown date as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 27Mar2021 the patient experienced and corrected 3 cognitive impairments shortly after waking up in the morning, while executing his morning coffee routine, in the space of 30 minutes he made 3 mistakes as follows. He poured the unground coffee beans into the coffee filter instead of the grinder which he had never done before. He put the plastic wrapper for the coffee packet into the yard waste instead of the trash which he has never done before. He lost his coffee cup and was unable to find it which he rarely does. The patient reported that all these happens less than once a year and he wish to clarify that he is not joking hence he had been doing the exact same things every morning for decades. The patient reported that he cannot assign this to anything other than the 2nd vaccine shot because he is isolated and he works from home, he also stated that his life has been quite routine and the only 'puncture' to his equilibrium has been his 2 trips to the hospital for the vaccine and he reported in the hope of helping out. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient had not received any treatments for the adverse event. The clinical outcomes of the events were resolved on an unspecified date in Mar2021 at the time of this report.   No follow-up attempts are needed. No further information expected.
looked flushed; Feels full; steady, moderate, dull headache; Fever of 102.4 degrees; dead arm, which means it felt like he got hit in the arm with a bat; Rough time sleeping last night; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (dead arm, which means it felt like he got hit in the arm with a bat), INSOMNIA (Rough time sleeping last night), FLUSHING (looked flushed), ABDOMINAL DISTENSION (Feels full) and HEADACHE (steady, moderate, dull headache) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, the patient experienced HYPOAESTHESIA (dead arm, which means it felt like he got hit in the arm with a bat) and INSOMNIA (Rough time sleeping last night). On 14-May-2021, the patient experienced FLUSHING (looked flushed), ABDOMINAL DISTENSION (Feels full), HEADACHE (steady, moderate, dull headache) and PYREXIA (Fever of 102.4 degrees). The patient was treated with PARACETAMOL at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (dead arm, which means it felt like he got hit in the arm with a bat), ABDOMINAL DISTENSION (Feels full) and HEADACHE (steady, moderate, dull headache) had not resolved and INSOMNIA (Rough time sleeping last night), FLUSHING (looked flushed) and PYREXIA (Fever of 102.4 degrees) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications on use were not provided.  No laboratory data was provided. Treatment included: 64 ounces of Gatorade, and soup.
felt sore; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (felt sore ) and FATIGUE (tired) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 02AL20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), CALCIUM, TRAMADOL and VITAMIN B COMPLEX for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced PAIN (felt sore ) and FATIGUE (tired). On 30-Jan-2021, PAIN (felt sore ) and FATIGUE (tired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   This case was linked to MOD-2021-043113 (Patient Link).
Fever around 100, chills, joint ache, headache, nausea, watery diarrhea, stomach pain, loss of appetite
Patient in for Moderna 0.25ml booster dose. Nurse drew up and gave 0.02ml dose. Patient returned from waiting are and was given full 0.25ml dose.
Myalgia CHILLS/FATIGUE/PAIN AT INJECTION SITE Narrative:
feels weak; nausea; wasn't feeling right; chills; within 15 minutes of shot felt high for about an hour after; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feels weak), EUPHORIC MOOD (within 15 minutes of shot felt high for about an hour after), NAUSEA (nausea), CHILLS (chills) and FEELING ABNORMAL (wasn't feeling right) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Aug-2021, the patient experienced EUPHORIC MOOD (within 15 minutes of shot felt high for about an hour after). On 16-Aug-2021, the patient experienced ASTHENIA (feels weak), NAUSEA (nausea) and CHILLS (chills). 16-Aug-2021, the patient experienced FEELING ABNORMAL (wasn't feeling right). On 14-Aug-2021, EUPHORIC MOOD (within 15 minutes of shot felt high for about an hour after) had resolved. At the time of the report, ASTHENIA (feels weak), NAUSEA (nausea), CHILLS (chills) and FEELING ABNORMAL (wasn't feeling right) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product was not provided by the reporter. Treatment information was not provided.
Information has been received on 02-MAR-2017 from a physician regarding a female patient of unknown age (reported as a child.) The patient's concurrent conditions, medical history and concomitant therapy were not reported. In the fall of 2015, the patient was vaccinated with PROQUAD (lot number and expiration not reported) subcutaneous for prophylaxis and was also vaccinated with a dose of FLUMIST (INTRANASAL (COLD) in the fall of 2015, with the doses of the vaccines given 2 weeks apart from one another. No adverse effects were reported. No additional information was available. Additional information is not expected because the reported did not give consent to follow up.
chest pains; This is a spontaneous report received from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration on 12Apr2021 at 08:44 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced chest pains. It was reported that patient started experiencing chest pains. Chest pains has been sharp and intense pressure at times. They occur for approximately up to 30 seconds and subside. Intervals of time between has been sporadic and intensity varies. They were more painful in the afternoon but were subsided slightly in pain and duration as the day continued to go on. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.  ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021420979 same reporter/drug/AE, different patient
Fevers of over 102 and vomiting (twice).  Aches and extreme fatigue starting about 8 hours after injection and lasting over 24 hours.
Patient was vaccinated at 1125 on 03/20/2021, in the left bicep. Presented to the observation area at 1135 with progressively worsening throat and ear discomfort described as "itching." EMTs immediately placed patient on the monitor and collected a set of vital signs.   Patient denies having LOC, syncopal episode, confusion, visual changes, generalized weakness, n/v, lightheadeness, dizziness, changes in vision, respiratory distress, sob, abdominal pain, n/v/d, swelling to the tongue or throat, feeling clammy or other associated symptoms at this time. Patient reported history of IV benadryl anaphylaxis. Provider administered 50 mg of Benadryl, by mouth, with water, at 1148. Patient tolerated medication well. Sister at bedside. Paramedics notified at 1145 and arrived at patient's bedside at 1158. Patient left at 1215 on stretcher with all personal belongings.
ALMOST KILLED ME; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced almost killed me. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of almost killed me was not reported. This report was non-serious.
Fever,chills, joint pain, muscle pain, fatigue, Swelling lymph nodes roght side, rash from chest trunk and back
I have been having constipation since early June. I have not been able to use the bathroom very much at all. This has been going on for about 10 months so far. I had a change made in my Synthroid dosage about 6 weeks after the second dose. I'm not sure if that had anything to do with the constipation, but I just want to mention it.
Vomited and could not hold anything down for eight days. Was in and out of the hospital, and they admitted me when they discovered I had colitis - probably as a result of the vaccine. We discovered that I was positive for the C-Diff antigen - probably because my brother had it six years ago - so they are calling it C-Diff colitis. They also discovered that I have bile going the wrong way, but that was probably there before the vaccine. I have bile acid gastritis and duodenitis. I was in the hospital Dec. 2-Dec. 5, and I vomited at least once after I left the hospital. I am still very, very, very nauseous, dizzy and I have abdominal pain that is much worse than normal.
On initial assessment, client found sliding  downwards from the chair, skin pale, diaphoretic, cool to touch, speech slurred. Client aroused to verbal stimuli. Client transferred to cot after ~ 15 seconds. Able to ambulate to observation with assistance.
Left arm swelling after immz on 3/15/06. Swelling started 24 hours after immz given on 3/16/06. Benadryl and cool pack given. Swelling resolved.
This spontaneous report was received from a registered nurse and refers to a 12 month old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 18-JUL-2017, the patient was vaccinated with an improperly stored VARIVAX at a dose of 0.5 (units not specified) from lot # N000683 with expiry date: 06-JAN-2019 (dose number, route, anatomical location and site of administration were not reported) for prophylaxis. Concomitant medications included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1707USA004945.